所有图片(1)
别名:
3-吡啶甲酸, 吡啶-3-羧酸, 尼亚生, 抗糙皮病因子, 维生素 B3
经验公式（希尔记法）:
C6H5NO2
CAS号:
分子量:
123.11
Beilstein:
109591
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24
推荐产品
生物来源
synthetic
等级
pharmaceutical primary standard
Agency
EP
API类
nicotinic acid
形式
solid
制造商/商品名称
EDQM
技术
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
mp
236-239 °C (lit.)
应用
pharmaceutical (small molecule)
格式
neat
储存温度
2-8°C
SMILES字符串
OC(=O)c1cccnc1
InChI
1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
InChI key
PVNIIMVLHYAWGP-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
Nicotinic acid is a type of vitamin B that is effective against dyslipidemia. It can also be potentially used as a peripheral vasodilator.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Nicotinic acid may be used as an EP reference standard for the determination of the analyte in pharmaceutical formulations by various chromatography techniques.
包装
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他说明
Sales restrictions may apply.
相关产品
产品编号
说明
价格
警示用语：
Warning
危险声明
预防措施声明
危险分类
Eye Irrit. 2
WGK
WGK 1
闪点(°F)
379.4 °F
闪点(°C)
193 °C
Development and optimisation of a generic micellar electrokinetic capillary chromatography method to support analysis of a wide range of pharmaceuticals and excipients
Altria KD and McLean R
Journal of Pharmaceutical and Biomedical Analysis, 18(4-5), 807-813 (1998)
Nicotinic acid
European Pharmacopoeia Commission and European Directorate for the Quality of Medicines & Healthcare
European pharmacopoeia, 5(2), 4961-4962 (2017)
Simultaneous Estimation of Meclizine Hydrochloride and Nicotinic Acid in Pharmaceutical Dosage form by RP-HPLC Method
REDDY S, et al.
Asian Journal of Pharmaceutical Research and Health Care, 5(2) (2013)
RP-HPLC method for the determination of atorvastatin calcium and nicotinic acid in combined tablet dosage form
Shah DA, et al.
Indian Journal of Pharmaceutical Sciences, 69(5), 700-700 (2007)
Janet E Digby et al.
Current opinion in lipidology, 20(4), 321-326 (2009-06-06)
Nicotinic acid is the most potent treatment clinically available for lowering LDL cholesterol and VLDL cholesterol and raising HDL cholesterol. The strong inverse relationship between coronary heart disease risk and HDL cholesterol at all levels of LDL cholesterol has, therefore
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门